• InflaCalm SAP may be used in the treatment of acute and chronic pain;
• InflaCalm SAP may be used in the treatment of musculoskeletal injuries;
• InflaCalm SAP may be used to enhance postsurgical recovery and wound healing;
• InflaCalm SAP may be considered for use in the adjunctive treatment and prevention of chronic inflammatory disorders.
Each enteric-coated vegetable capsule contains:
Bromelain (2400 GDU/g) ... 150 mg
Curcumin extract (95% curcuminoids) ... 150 mg
Quercetin dihydrate 98% ... 100 mg
Rutin... 100 mg
Trypsin... 50 mg
Boswellia serrata (70% boswellic acids) ... 100 mg
Serratiopeptidase (2400 u/mg) ... 20 mg
Piper nigrum (Black pepper) extract (95% piperine) ... 1.5 mg
Contains no: Preservatives, artificial flavour or colour, sugar, dairy, starch, wheat, gluten, yeast, soy, citrus, corn or egg.
The prostaglandins are a class of hormone-like compounds called eicosanoids, which have biological activities in tissue repair and inflammation, amongst other actions. The prostaglandin 2 series (PG 2) are known to be potent proinflammatory mediators synthesized by the cyclooxygenase (COX) enzymes, while the prostaglandin 1 (PG 1) and prostaglandin 3 (PG 3) series have anti-inflammatory action. Managing the balance of prostaglandins is a major aspect of mitigating pain and inflammation, and the modulation of the COX and other enzymes controlling the production of inflammatory mediators is the target of therapy. The components of InflaCalm SAP in synergistic combination maximize the delivery, absorption, and thereby anti inflammatory effect of these well-researched nutraceuticals and herbs.
90 or 180 enteric-coated capsules per bottle
Take 2 capsules once or twice times daily or as directed by your licensed health care practitioner.
Do not take InflaCalm SAP without consulting your licensed health care practitioner if you
have a history of peptic ulcer disease, are currently undergoing chemotherapy, are pregnant or
breast-feeding, are concurrently taking blood thinning medications or other anti-inflammatory
medications, have gallstones or bile duct obstruction, or have a known allergy to pineapple.
1. [No authors mentioned]. “Bromelain. Monograph.” Alternative Medicine Review 15,
No. 4 (2010): 361–368.
2. Wallace, J.M. “Nutiritional and botanical modulation of the inflammatory cascade—
eicosanoids, cyclooxygenases, and lipoxygenases—as an adjunct in cancer therapy. “
Integrative Cancer Therapies 1, No. 1 (2002): 7–37.
3. Suresh, D. and K. Srinivasan. “Tissue distribution & elimination of capsaicin, piperine
& curcumin following oral intake in rats”. Indian Journal of Medical Research 131
4. Shoba, G., D. Joy, T. Joseph, et al. “Influence of piperine on the pharmacokinetics of
curcumin in animals and human volunteers”. Planta Medica 64, No. 4 (1998): 353–356.
5. Al-Khateeb, T.H. and Y. Nusair. “Effect of the proteolytic enzyme serrapeptase on
swelling, pain and trismus after surgical extraction of mandibular third molars”.
International Journal of Oral Maxillofacial Surgery 37, No. 3 (2008): 264–268.
6. Jadav, S.P., N.H. Patel, T.G. Shah, et al. “Comparison of anti-inflammatory activity
of serratiopeptidase and diclofenac in albino rats”. Journal of Pharmacology &
Pharmacotherapeutics 1, No. 2 (2010): 116–117.
7. Klein, G., W. Kullich, J. Schnitker, and H. Schwann. “Efficacy and tolerance of an oral
enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised
study comparing oral enzymes with non-steroidal anti-inflammatory drugs”. Clinical
and Experimental Rheumatology 24, No. 1: 25–30.
8. Szczurko, O., K. Cooley, E.J. Mills, et al. “Naturopathic treatment of rotator cuff
tendinitis among Canadian postal workers: a randomized controlled trial”. Arthritis &
Rheumatism 61, No. 8 (2009): 1037–1045.
9. Kelly, G.S. “Quercetin. Monograph”. Alternative Medicine Review 16, No. 2 (2011):
10. Xiao, X., D. Shi, L. Liu, et al. “Quercetin suppresses cyclooxygenase 2 expression and
angiogenesis through inactivation of P300 signaling”. PLoS One 6, No. 8: e22934.
11. Thornhill, S.M. and A.M. Kelly. “Natural treatment of perennial allergic rhinitis”.
Alternative Medicine Review 5, No. 5 (2000): 449–54.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.